Healthcare provider profile · identity verified

Andrea Drown, DO

Family Practice · MARYSVILLE, WA · NPI 1225297385

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	520	190
Levothyroxine Sodium	Levothyroxine Sodium	433	147
Losartan Potassium	Losartan Potassium	302	99
Lisinopril	Lisinopril	298	114
Omeprazole	Omeprazole	273	91
Amlodipine Besylate	Amlodipine Besylate	236	89
Hydrochlorothiazide	Hydrochlorothiazide	201	69
Trazodone Hcl	Trazodone Hcl	185	65
Metformin Hcl Er	Metformin Hcl	180	68
Gabapentin	Gabapentin	168	70
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	167	29
Sertraline Hcl	Sertraline Hcl	156	47
Simvastatin	Simvastatin	154	50
Pantoprazole Sodium	Pantoprazole Sodium	137	49
Metoprolol Succinate	Metoprolol Succinate	133	52
Oxycodone Hcl	Oxycodone Hcl	127	23
Rosuvastatin Calcium	Rosuvastatin Calcium	119	44
Potassium Chloride	Potassium Chloride	117	40
Atenolol	Atenolol	108	35
Tizanidine Hcl	Tizanidine Hcl	106	30
Ozempic	Semaglutide	104	26
Albuterol Sulfate Hfa	Albuterol Sulfate	100	57
Furosemide	Furosemide	97	39
Alendronate Sodium	Alendronate Sodium	95	34
Tamsulosin Hcl	Tamsulosin Hcl	95	38
Citalopram Hbr	Citalopram Hydrobromide	93	28
Zolpidem Tartrate	Zolpidem Tartrate	85	16
Metformin Hcl	Metformin Hcl	83	33
Glipizide Er	Glipizide	73	22
Jardiance	Empagliflozin	71	17
Tramadol Hcl	Tramadol Hcl	71	22
Meloxicam	Meloxicam	67	22
Duloxetine Hcl	Duloxetine Hcl	66	27
Allopurinol	Allopurinol	64	19
Bupropion Xl	Bupropion Hcl	64	19
Glimepiride	Glimepiride	61	24
Pravastatin Sodium	Pravastatin Sodium	61	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	58	27
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	12
Lovastatin	Lovastatin	53	17
Escitalopram Oxalate	Escitalopram Oxalate	52	22
Clopidogrel	Clopidogrel Bisulfate	51	22
Buspirone Hcl	Buspirone Hcl	49	suppressed
Naproxen	Naproxen	49	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	12
Mirtazapine	Mirtazapine	45	15
Baclofen	Baclofen	44	12
Estradiol	Estradiol	44	20
Famotidine	Famotidine	44	15
Alprazolam	Alprazolam	43	15
Donepezil Hcl	Donepezil Hcl	41	15
Fluticasone Propionate	Fluticasone Propionate	41	22
Pregabalin	Pregabalin	38	11
Lorazepam	Lorazepam	37	suppressed
Lamotrigine	Lamotrigine	36	suppressed
Finasteride	Finasteride	34	12
Ropinirole Hcl	Ropinirole Hcl	34	11
Spironolactone	Spironolactone	34	13
Diclofenac Sodium	Diclofenac Sodium	33	12
Triamcinolone Acetonide	Triamcinolone Acetonide	33	19
Venlafaxine Hcl Er	Venlafaxine Hcl	33	11
Bupropion Hcl Sr	Bupropion Hcl	32	13
Hydroxyzine Hcl	Hydroxyzine Hcl	32	14
Carvedilol	Carvedilol	31	14
Clonazepam	Clonazepam	30	suppressed
Methocarbamol	Methocarbamol	30	13
Metoprolol Tartrate	Metoprolol Tartrate	30	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Eliquis	Apixaban	26	suppressed
Ketoconazole	Ketoconazole	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	15
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Myrbetriq	Mirabegron	24	suppressed
Topiramate	Topiramate	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	11
Nystatin	Nystatin	21	13
Oxybutynin Chloride Er	Oxybutynin Chloride	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Celecoxib	Celecoxib	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Sucralfate	Sucralfate	18	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	17	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	17	suppressed
Fenofibrate	Fenofibrate	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Prednisone	Prednisone	17	17
Torsemide	Torsemide	17	suppressed
Benazepril Hcl	Benazepril Hcl	16	suppressed
Cephalexin	Cephalexin	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Temazepam	Temazepam	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Acyclovir	Acyclovir	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Nyamyc	Nystatin	15	suppressed
Risperidone	Risperidone	15	suppressed
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Synthroid	Levothyroxine Sodium	15	suppressed
Terazosin Hcl	Terazosin Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valsartan	Valsartan	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Fluconazole	Fluconazole	14	11
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Metronidazole	Metronidazole	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Valacyclovir	Valacyclovir Hcl	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Prazosin Hcl	Prazosin Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Mupirocin	Mupirocin	11	suppressed
Nabumetone	Nabumetone	11	suppressed
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error